Read R.J.’s article on PM360:
The fears behind pharma’s adoption of programmatic include:
- Quality and location ad placement.
- Various restrictions that come with some pharma advertising such as competitive exclusions.
- Fear of appearing on user-generated content (next to a random adverse event comment).
Global corporate policies restricting retargeting.